Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02616653
Other study ID # 15.251
Secondary ID
Status Completed
Phase N/A
First received November 25, 2015
Last updated February 28, 2017
Start date January 2016
Est. completion date February 2017

Study information

Verified date February 2017
Source Centre hospitalier de l'Université de Montréal (CHUM)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to determine the frequency of Tuffier's line overestimation (2 lumbar levels or more) when the palpation method is used in obese parturients at term in the lateral position compared to the sitting position.

Hypothesis: The L3-L4 intervertebral space identified by the palpation method will be two levels higher than the level determined by ultrasonography (US) more often in the lateral than in the sitting position.


Description:

For years now, anesthesiologists have used anatomical landmarks to guide neuraxial anesthesia and analgesia techniques in obstetric patients. Traditionally, Tuffier's line (intercristal line) has been used as a reference and corresponds to a horizontal line drawn between the upper part of the iliac crests that is thought to intersect the spine at the level of the L4 spinous process or the L4-L5 intervertebral space. However, many studies have found this anatomical landmark to be unreliable reporting the Tuffier's line to intersect the spine at levels ranging from the L3-L4 to L5-S1 intervertebral spaces. Regarding the obstetrical population, the anatomical position of the Tuffier's line was found to be even higher presumably due to the exaggerated lordosis of pregnancy.

Neuraxial techniques used for obstetrical anesthesia and analgesia include epidurals, spinals and combined epidural-spinal (CSE) techniques. The correct identification of the intervertebral space for neuraxial analgesia and anesthesia is very important especially if using a spinal injection such as is done when performing a CSE.

Neuraxial techniques can be done in the sitting or the lying lateral position. When expecting a more challenging technique, such as in an obese patient, anesthesiologists will usually choose to perform the technique with patients in the sitting position. But the lateral position is preferred in certain conditions such as in premature rupture of membranes where there is a risk of umbilical cord prolapse, in women experiencing a vasovagal response caused by the needle insertion or upon assuming the sitting position, or because of the anesthesiologist's preference.

US-guided regional techniques are gaining popularity both for the general population as well as for the pregnant women. It has been shown to be a more reliable tool than the palpation method in identifying a specific lumbar intervertebral level. The use of US imaging for neuraxial techniques in pregnant women has been shown to reduce the numbers of attempts, improve the comfort of the patient during the procedure and increase the precision in identifying the intervertebral space at which the technique is being performed. Obesity can make regional techniques extremely challenging and US imaging becomes a valuable tool in this setting.

Methods:

Participants will be positioned on an exam table in the sitting position for the first half of the group and the lateral position for the other half. For the sitting position, the participants will have both feet supported by a foot rest while being asked to round back by lowering their head on their chest and pushing out their back to assume a fetal like position. If necessary, the women may be asked to hold a pillow to improve their position to get the ideal conditions for the palpation of the Tuffier's line and intervertebral spaces. For the lateral position, the participants will be placed on the left lateral side with flexion of the knees and hip, and flexion of the head and neck with a pillow supporting them. Again, the women will be instructed to adopt a fetal position by rounding their back.

An anesthesiologist who is assigned to the obstetrical floor for the day and who is not an investigator in this study will be asked to perform the palpation method. He/she will proceed with the identification of the Tuffier's line (upper part of the iliac crests) and determine the level of intersection with the spine. This anatomical landmark will then be used to estimate the location of the L3-L4 intervertebral space which is the space frequently chosen to proceed to a neuraxial technique. Once the level is identified, it will be marked and hidden under a hypoallergenic paper tape. The anesthesiologist will then leave the room while the investigator trained in US imaging will proceed to the US exam of the spine specifically aiming to identify the L3-L4 intervertebral space. Once located, the investigator will be able to look at the skin mark made by the anesthesiologist and compare it to the level he/she will have determined to be at the L3-L4 level by US imaging. The investigator will note if the same level was identified and if not, which one was according to the US exam. The paper tape will be reapplied over the lumbar spine to mask any anatomical marks (birth marks or scars) that may influence the anesthesiologist who will be asked to step in again to proceed to the palpation method in the other position, again marking the area which he/she thinks corresponds to the L3-L4 space. US imaging will be repeated in the second position and the level obtained by the exam will be compared to the one obtained by the palpation method in the same way as the first position. The investigators expect the total time for the procedure to be of 20-30 minutes. Participants will be asked to rate their level of comfort during the procedure in both positions using a verbal rating scale from 0 to 10.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date February 2017
Est. primary completion date February 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Obese pregnant women (BMI equal or superior to 30)

- Pregnancy at term (37 weeks or more)

Exclusion Criteria:

- American Society of Anesthesiologists' physical status of 4 or 5

- Scoliosis or any other anomaly of the spine

- Prior spine surgery

- Inability to assume the correct position due to back pain

- Inability to collaborate

- Labouring women

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
L3-L4 location: Palpation method confirmed by US
An anesthesiologist will locate the L3-L4 space using the palpation method (Tuffier's line). An investigator trained in US imaging will proceed to the US exam of the spine specifically aiming to identify the L3-L4 intervertebral space. The investigator will note if the same level was identified and if not, which one was according to the US exam.

Locations

Country Name City State
Canada Centre Hospitalier de l'Université de Montréal (CHUM) Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Centre hospitalier de l'Université de Montréal (CHUM)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Estimation of Tuffier's line using the palpation method Incidence of overestimation of the Tuffier's line (2 lumbar levels or more) using the palpation method in the sitting position compared to the lateral position On Day one during medical appointment at the obstetrics clinic
Secondary Impact of fundal height on estimation of the Tuffier's line using the palpation method Impact of fundal height on overestimation of the Tuffier's line using the palpation method in the sitting position compared to the lateral position On Day one during medical appointment at the obstetrics clinic
Secondary Comfort level using a verbal rating scale Level of comfort during the procedure in the sitting and lateral positions using a verbal rating scale (0 being totally comfortable, 10 totally uncomfortable) On Day one during medical appointment at the obstetrics clinic
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2